Received: 28 February 2022
Accepted: 12 July 2022
First Online: 30 September 2022
: Approval of the study protocol was obtained from the Institutional Review Board (IRB) of Bangabandhu Sheik Mujib Medical University (BSMMU) (BSMMU/ 2018/5657). Informed written consent was obtained from each participant before enrollment. A complete assurance was given that all information would be kept confidential. The right was given to the patients not to participate and to discontinue participation in the study with consideration/without penalty. The Declaration of Helsinki’s ethical guidelines were followed in the study.
: Not applicable.
: The authors declare that they have no competing interests. The authors alone are responsible for the views expressed in this article. They do not necessarily represent the views, decisions, or policies of the institutions affiliated.